Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
11/26/2008 | EP1994153A2 Chimeric kunitz domains and their use |
11/26/2008 | EP1994139A1 Live attenuated bordetella strains as a single dose vaccine against whooping cough |
11/26/2008 | EP1994138A2 Process for preparing human g-csf |
11/26/2008 | EP1994053A1 Soluble gp130 molecule variants useful as a medicament |
11/26/2008 | EP1994050A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof |
11/26/2008 | EP1543142B1 Production method for iturin a and its homologues |
11/26/2008 | EP1417346B1 Method for identifying macrocyclic polyketides |
11/26/2008 | EP1404836B1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
11/26/2008 | EP1307478B1 Luxr gene from coryneform bacteria and a process for the production of l-amino acids |
11/26/2008 | EP0821732B1 Altered polypeptides with increased half-life |
11/26/2008 | CN101311273A Biosynthesis gamma-aminobutyric acid preparation and method for preparing same |
11/26/2008 | CN101311271A Process for producing cellulosic ethanol by recombining saccharomyces cerevisiae |
11/26/2008 | CN101311268A Expression and applications of novel non-restriction endonuclease in escherichia coli |
11/26/2008 | CN101311262A Streptomyces griseus and uses thereof |
11/26/2008 | CN101311261A Continuous culture process of anaerobe strain |
11/26/2008 | CN101311260A Method for preparing amanita vittadinii mycelium fermentation liquor preparation |
11/26/2008 | CN101311259A Microorganism decomposition agent and method for preparing same |
11/26/2008 | CN101311192A Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof |
11/26/2008 | CN100436594C Method for the production of S-adenosylmethionine by fermentation |
11/26/2008 | CN100436593C Process for producing sugar nucleotides and complex carbohydrates |
11/26/2008 | CN100436586C Endoglucanase NCE5 and cellulase preparations contg. same |
11/26/2008 | CN100436581C Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
11/26/2008 | CN100436579C Vitreoscilla hemoglobin gene and its uses |
11/26/2008 | CN100436576C Nattokinase and its coding gene and clone and expressing method |
11/26/2008 | CN100436575C Heteromorphic Dactlella bacterial agent capable of killing nematode and application thereof |
11/26/2008 | CN100436392C Method of culturing and extracting veralkaol using polygonum cuspidatum produced verakaol endogenic bacteria |
11/26/2008 | CN100435850C Combination of medication produced from attenuated salmonella bacteria possessing effect of radiation protection and anti tumour |
11/26/2008 | CN100435845C Live attenuated vaccine against porcine pleuropneumonia |
11/25/2008 | US7456298 Providing an aryl silane substrate having at least one aromatic component and at least one silicon atom, contacting a dioxygenase enzyme with the substrate to convert the aryl silane substrate to a corresponding cis-diol; Dimethylphenylvinylsilane cis-diol acetonide |
11/25/2008 | US7456276 Peptide purification by means of metal ion affinity chromatography |
11/25/2008 | US7456272 Neurotoxins with enhanced target specificity |
11/25/2008 | US7456269 Alzheimer's disease secretase, APP substrates thereof, and uses thereof |
11/25/2008 | US7456264 Human monoclonal antibodies against Bacillus anthracis protective antigen |
11/25/2008 | US7456263 P53 binding T cell receptor molecules |
11/25/2008 | US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation |
11/25/2008 | US7456018 Human hepatoma lines, methods for obtaining same and uses thereof |
11/25/2008 | US7456014 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA |
11/25/2008 | US7456011 For delivering a therapeutic protein to the mucosal surface of human vagina or gastrointestinal tract; binds to gp 120 of human immunodeficiency virus (HIV) and inhibits the infectivity of HIV |
11/25/2008 | US7456010 Microorganism producing 5′-xanthylic acid |
11/25/2008 | US7456005 Modified xylanases exhibiting improved expression |
11/25/2008 | US7456003 Isolated protein having the enzymatic activity of an amylosucrase produced by recombinant DNA |
11/25/2008 | US7456001 A polynucleotide encoding a lipoxygenase and its use for recombinant production of a lipoxygenase; obtaining a lipoxygenase by screening a DNA library with specific probes |
11/25/2008 | US7455999 Synthesizing polyhydroxyalkanoate in a transgenic organism having transgene encoding an enzyme selected from PHB polymerase, PHA polymerase, beta-ketothiolase, beta -ketoacyl-CoA reductase, etc., integrated into chromosome |
11/25/2008 | US7455998 Methods for forming structurally defined organic molecules |
11/25/2008 | US7455996 From sucrose and galactinol; biosynthesis; chromatography; electrophoresis |
11/25/2008 | US7455990 Isolating hexose oxidase for use as tool in enhancement of nutrient quality of animal feeeds |
11/25/2008 | US7455987 Signal sequences for preparing leu-hirudin by secretion by E. coli into the culture medium |
11/25/2008 | US7455983 Nutrient broth for propagation of progenitor cells for use in drug screeniing and human therapy |
11/25/2008 | US7455981 Method of detecting broad-spectrum delta-endotoxins |
11/25/2008 | US7455963 Antibodies to cyclin E2 protein |
11/25/2008 | US7455155 Impact absorbent assembly in slope protection systems |
11/25/2008 | CA2303416C Repressed trans-activator system for characterization of protein-protein interactions |
11/25/2008 | CA2235771C Rhodosporidium d-amino acid oxidase |
11/20/2008 | WO2008141226A2 Recombinant bacteria comprising vectors for expression of nucleic acid sequences encoding antigens |
11/20/2008 | WO2008141174A2 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof |
11/20/2008 | WO2008140862A1 Optimization of colicin production |
11/20/2008 | WO2008140812A2 Compositions and methods comprising klk3, psca, or folh1 antigen |
11/20/2008 | WO2008140749A2 Compositions and methods for enhancing the degradation or conversion of cellulose-containing material |
11/20/2008 | WO2008140615A2 Modified messenger rna stabilizing sequences for expressing genes in bacterial cells |
11/20/2008 | WO2008140353A1 AGENT EXHIBITING PROPERTIES TO FORM THE CELLULAR IMMUNITY AGAINST MYCOBACTERIUM TUBERCULOSIS H37 Rv, METHOD FOR THE PRODUCTION THEREOF (VARIANTS), A RECOMBINANT STRAIN AND AN AGENT FOR TUBERCULOSIS DIAGNOSIS |
11/20/2008 | WO2008140307A1 Method for concentrating microbiological organisms suspended in a flowing liquid |
11/20/2008 | WO2008139844A1 Method for producing glucuronic acid by glucuronic acid fermentation |
11/20/2008 | WO2008139641A1 Method for producing cellulase and hemicellulase having high hydrolytic activity |
11/20/2008 | WO2008139591A1 Method of producing recombinant aprotinin |
11/20/2008 | WO2008139572A1 Cell isolation method |
11/20/2008 | WO2008139494A1 Process for obtaining bioactive recombinant protein from inclusion bodies |
11/20/2008 | WO2008139488A1 A process for the production of organic formulation of bio-pesticide pseudomonas fluorescens. |
11/20/2008 | WO2008138839A2 Preparation of cosmetic active principles by culturing vitreoscilla on thermal water and compositions comprising them |
11/20/2008 | WO2008138559A1 Method for isolating glucan |
11/20/2008 | WO2008121563A3 Modified fgf-21 polypeptides and their uses |
11/20/2008 | WO2008117266A3 Probiotic bifidobacterium strains |
11/20/2008 | WO2008102253A3 Method of biosynthesizing tetrodotoxin |
11/20/2008 | WO2008100816A3 Antibody libray display by yeast cell plasma membrane |
11/20/2008 | WO2008093280A3 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
11/20/2008 | WO2008082726A8 Real time monitoring of microbial enzymatic pathways |
11/20/2008 | WO2008048513A3 Ethanol resistant and furfural resistant strains of e. coli fbr5 for production of ethanol from cellulosic biomass |
11/20/2008 | WO2008018930A3 Ethanol production in non-recombinant hosts |
11/20/2008 | WO2007120541A3 Method for cloning and expression of nrui restriction endonuclease |
11/20/2008 | WO2007076166A3 Methods of making modular fusion protein expression products |
11/20/2008 | US20080289066 Self-Processing Plants and Plant Parts |
11/20/2008 | US20080289062 Sorghum aluminum tolerance gene, SbMATE |
11/20/2008 | US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods |
11/20/2008 | US20080287665 CANINE IgG NUCLEIC ACID MOLECULES |
11/20/2008 | US20080287546 Quorum Sensing Modulators |
11/20/2008 | US20080287483 Polyketides and Their Synthesis and Use |
11/20/2008 | US20080287482 Production of Polyketides and Other Natural Products |
11/20/2008 | US20080287388 Human G-Protein Coupled Receptor |
11/20/2008 | US20080287362 Compositions and Methods for the Detection of Trypanosoma Cruzi Infection |
11/20/2008 | US20080287356 Chimeric Proteins, Their Preparation and Pharmaceutical Compositions Containing Them |
11/20/2008 | US20080287349 Fibroblast growth factor 20 and methods of use thereof |
11/20/2008 | US20080287346 Bioactive peptides |
11/20/2008 | US20080287345 Polymyxin derivatives and uses thereof |
11/20/2008 | US20080287304 Mixture of at Least Two Fusion Proteins as Well as Their Production and Use |
11/20/2008 | US20080286871 Modular genomes for synthetic biology and metabolic engineering |
11/20/2008 | US20080286870 Xylitol synthesis mutant of xylose-utilizing zymomonas for ethanol production |
11/20/2008 | US20080286861 Compositions and Methods for the Treatment of Immune Related Diseases |
11/20/2008 | US20080286853 Process for Producing a Bio-Pesticide Composition Containing Trichoderma Harzianum and Pseudomonas Fluorescens |
11/20/2008 | US20080286852 Immunogens; shuttle vectors; do not display antibiotic resistance, and do not exhibit horizontal transfer to gram-negative bacteria |
11/20/2008 | US20080286851 Large-scale photo-bioreactor using flexible materials, large bubble generator, and unfurling site set up method |
11/20/2008 | US20080286844 Metabolically Engineered Cells for the Production of Resveratrol or an Oligomeric or Glycosidically-Bound Derivative Thereof |